learn PP405
mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
Search
forLearn
5 / 33 resultslearn Pyrilutamide
highly targeted anti-androgen that might have minimal systemic effects
learn Overview
learn Osteopontin
signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss
learn Thymosin Beta 4
Research
5 / 1000+ resultsresearch Three-Dimensional Imaging for Facial Vitiligo: Results from a Phase 2 Randomized Controlled Trial Investigating Upadacitinib in Patients with Vitiligo
3D imaging effectively tracks skin changes in vitiligo treatment.
research Methodological Considerations in Evaluating Early Clinical Outcomes of GT20029 for Androgenetic Alopecia
GT20029 showed some hair growth improvement, but longer studies are needed for better results.
research Comparison of Pemetrexed and Docetaxel as Salvage Chemotherapy for the Treatment of Non-Small-Cell Lung Cancer After the Failure of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.
research Safety and Compatibility of a New Nourishing Baby Shampoo and Tip to Toe Wash with Stearic Acid
The new baby shampoo and wash with stearic acid is safe and potentially effective for nourishing babies' skin.
research Safety and Efficacy of Actinic Keratoses Reduction with a 3-Day Application of Ingenol Disoxate Field Treatment to the Face, Chest, and Balding Scalp
The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.
Community Join
5 / 1000+ resultscommunity Why is there more skepticism in RU than Pyrilutamide?
The conversation is about skepticism towards the hair loss treatments RU58841 and Pyrilutamide, with users discussing the lack of human testing for RU58841 and the ongoing trials for Pyrilutamide. Some users believe RU58841 has more anecdotal success, while others highlight Pyrilutamide's current research progress.
community We are in September and heard nothing from the HMI-115 trial
The user is frustrated about not hearing any updates on the HMI-115 trial for hair loss. They are questioning if there will be any updates in the future.
community Wasn’t hmi-115 phase 1 supposed to end in july? We’ve heard nothing so far
The conversation is about the delay in receiving updates on the HMI-115 phase 1 trial for hair loss. No specific treatments are mentioned in the conversation.
community Chances of GT20029 hitting the black market?
The conversation is about the potential availability of GT20029 on the black market and whether users would try it. Participants advise waiting for phase 3 trial results to ensure safety and efficacy.
community When will HMI-115 second trail be over?
A clinical trial for hair loss treatments involving Minoxidil, Finasteride, and RU58841, and when the results of the trial will be available.